State Street Corporation filed a Schedule 13G with the SEC on November 9, 2026, disclosing beneficial ownership of 13,675,348 shares of ADMA Biologics Inc. common stock as of September 30, 2026.

Key Highlights

  • Aggregate beneficial ownership: State Street Corporation reported beneficial ownership of 13,675,348 shares of ADMA Biologics Inc. common stock, representing 6.1% of the class.
  • Shared voting power: State Street disclosed shared voting power over 12,892,596 shares, with sole voting power reported as 0.
  • Shared dispositive power: The filing reports shared dispositive power over 13,675,348 shares, with sole dispositive power reported as 0.
  • Triggering date: The event requiring the filing occurred on September 30, 2026, according to the statement.
  • Filing entity type: State Street Corporation identified itself as a parent holding company (type "HC") organized in Massachusetts.
  • Subsidiaries involved: The filing identifies five subsidiaries as the relevant entities that acquired the securities, including SSGA Funds Management, Inc. and State Street Global Advisors Europe Limited, each classified as an investment adviser (IA).

State Street Corporation's Schedule 13G Disclosure on ADMA Biologics

State Street Corporation, headquartered at One Congress Street, Suite 1, Boston, MA 02114, filed a Schedule 13G disclosing its position in ADMA Biologics Inc. (issuer address: 465 Route 17 South, Ramsey, New Jersey, 07446). The filing was signed by Alok Maheshwary, Senior Vice President, and dated November 9, 2026. The filing covers common stock with CUSIP number 000899104.

According to the filing, State Street's aggregate beneficial ownership stands at 13,675,348 shares, equal to 6.1% of the outstanding class. The reporting person holds no sole voting or sole dispositive power over any shares. Shared voting power covers 12,892,596 shares, while shared dispositive power extends to the full 13,675,348 shares reported as beneficially owned.

The filing identifies five subsidiaries through which the securities are held, all classified as investment advisers: SSGA Funds Management, Inc.; State Street Global Advisors Europe Limited; State Street Global Advisors Limited; State Street Global Advisors Trust Company; and State Street Global Advisors, Ltd. The filing certifies, in the words of the statement, that the securities "were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer."

What Was Disclosed

State Street Corporation disclosed a 6.1% beneficial ownership position in ADMA Biologics Inc. common stock as of September 30, 2026, totaling 13,675,348 shares held through five investment adviser subsidiaries, with all voting and dispositive power shared rather than sole.